TrialThe oncologist2016

Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3).

Sunil Verma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.